GUILLAUME LAMOTTE portrait
  • Assistant Professor (Clinical), Neurology
801-585-7575

Languages

  • English, Fluent.
  • French, Fluent.

Publications

  • Lamotte G, Millar Vernetti P (date unknown). Inhibition of the norepinephrine transporter to treat neurogenic orthostatic hypotension: is this the end of the story?. Vol. 31, 645-647. Accepted, .
  • Lamotte G, Becker B (date unknown). Toward biomarker-based clinical subtyping of Parkinson disease. Vol. 95, 461-462. Accepted, .
  • Lamotte G, Boes CJ, Low PA, Coon EA (date unknown). The expanding role of the cold pressor test: a brief history. Vol. 31, 153-155. Accepted, .
  • Lamotte G, Goldstein DS (date unknown). What new can we learn from cardiac sympathetic neuroimaging in synucleinopathies?. Accepted, .
  • Guillaume L, Denis A (date unknown). Cardiac 123I-MIBG scintigraphy: A window into the brain in Parkinsonism?. Vol. 24, 108-110. Accepted, .
  • Lamotte G, Farzal Z, Zimmerman WD, Han S, de Brito P, Mayson D (date unknown). Clinical Reasoning: Monocular vision loss, ophthalmoplegia, and strokes in a 61-year-old man with diabetes mellitus. Vol. 89, e276-e281. Accepted, .
  • Goldstein DS, Isonaka R, Lamotte G, Kaufmann H (date unknown). Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies. Vol. 31, 677-684. Accepted, .
  • Lamotte G, Holmes C, Sullivan P, Lenka A, Goldstein DS (date unknown). Cardioselective peripheral noradrenergic deficiency in Lewy body synucleinopathies. Vol. 7, 2450-2460. Accepted, .
  • Laureno R, Lamotte G (date unknown). The midline cerebellar lesion in experimental Wernicke disease. Vol. 69, 1624. Accepted, .
  • Lamotte G, Shouman K, Benarroch EE (date unknown). Stress and central autonomic network. Vol. 235, 102870. Accepted, .
  • Castillo-Pinto C, Lamotte G, et al (date unknown). Healthcare Worker With Large Vessel Acute Ischemic Stroke Likely Related to Mild SARS-CoV-2 Infection. Accepted, .
  • Laureno R, Lamotte G, Mark AS (date unknown). Sequential MRI in pontine and extrapontine myelinolysis following rapid correction of hyponatremia. Vol. 11, 707. Accepted, .
  • Lamotte G, Sandroni P (date unknown). A practical approach to peripheral autonomic neuropathies. Vol. 34, 638-647. Accepted, .
  • Lamotte G, Sandroni P, Cutsforth-Gregory JK, Berini SE, Benarroch EE, Shouman K, Mauermann ML, Anderson J, Low PA, Singer W, Coon EA (date unknown). Clinical presentation and autonomic profile in Ross syndrome. Vol. 268, 3852-3860. Accepted, .
  • Lamotte G, Holmes C, Wu T, Goldstein DS (date unknown). Long-term trends in myocardial sympathetic innervation and function in synucleinopathies. Vol. 67, 27-33. Accepted, .
  • Lamotte G, Williams C (date unknown). Mystery Case: A case of fulminant encephalopathy in a 69-year-old woman. Vol. 89, e109-e114. Accepted, .
  • Lamotte G, Takahashi M, Wu T, Sullivan P, Cherup J, Holmes C, Goldstein DS (date unknown). Do indices of baroreflex failure and peripheral noradrenergic deficiency predict the magnitude of orthostatic hypotension in Lewy body diseases?. Vol. 31, 543-551. Accepted, .
  • Lamotte G (date unknown). Central pontine myelinolysis secondary to rapid correction of hyponatremia historical perspective with Doctor Robert Laureno. Vol. 42, 3479-3483. Accepted, .
  • Lamotte G, Coon EA, Suarez MD, Sandroni P, Benarroch EE, Cutsforth-Gregory JK, Mauermann ML, Berini SE, Shouman K, Sletten D, Goodman BP, Low PA, Singer W (date unknown). Natural History of Afferent Baroreflex Failure in Adults. Vol. 97, e136-e144. Accepted, .
  • Goldstein DS, Sullivan P, Holmes C, Lamotte G, Lenka A, Sharabi Y (date unknown). Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies. Vol. 158, 554-568. Accepted, .
  • Lamotte G, Shah RC, Lazarov O, Corcos DM (date unknown). Exercise Training for Persons with Alzheimer's Disease and Caregivers: A Review of Dyadic Exercise Interventions. Vol. 49, 365-377. Accepted, .
  • Lamotte G, Morello R, Lebasnier A, Agostini D, Bouvard G, De La Sayette V, Defer GL (date unknown). Influence of education on cognitive performance and dopamine transporter binding in dementia with Lewy bodies. Vol. 146, 138-43. Accepted, .
  • Shouman K, Vanichkachorn G, Cheshire WP, Suarez MD, Shelly S, Lamotte GJ, Sandroni P, Benarroch EE, Berini SE, Cutsforth-Gregory JK, Coon EA, Mauermann ML, Low PA, Singer W (date unknown). Autonomic dysfunction following COVID-19 infection: an early experience. Vol. 31, 385-394. Accepted, .
  • Lebasnier A, Lamotte G, Manrique A, Peyronnet D, Bouvard G, Defer G, Agostini D (date unknown). Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases. Vol. 42, 1043-51. Accepted, .
  • Lamotte G, Morello R, Lebasnier A, Agostini D, Defer GL (date unknown). Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses. Vol. 15, 83. Accepted, .
  • Lenka A, Mittal SO, Lamotte G, Pagan FL (date unknown). A Pragmatic Approach to the Perioperative Management of Parkinson's Disease. Vol. 48, 299-307. Accepted, .
  • Lamotte G, Benarroch EE (date unknown). What Is the Clinical Correlation of Cardiac Noradrenergic Denervation in Parkinson Disease?. Vol. 96, 748-753. Accepted, .
  • Lamotte G (date unknown). Author response: Mystery Case: A case of fulminant encephalopathy in a 69-year-old woman. Vol. 90, 714. Accepted, .
  • Lenka A, Lamotte G, Goldstein DS (date unknown). Cardiac 18F-Dopamine PET Distinguishes PD with Orthostatic Hypotension from Parkinsonian MSA. Vol. 8, 582-586. Accepted, .
  • Lamotte G, Lenka A (date unknown). Brainstem Predominant Posterior Reversible Encephalopathy Syndrome. Vol. 69, 536-537. Accepted, .
  • Lamotte G, Holmes C, Sullivan P, Goldstein DS (date unknown). Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension. Vol. 29, 113-117. Accepted, .
  • Lamotte G, Agostini D (date unknown). Erratum to: Cardiac 123I-MIBG scintigraphy: A window into the brain in Parkinsonism?. Vol. 24, 111. Accepted, .
  • Lamotte G, Skender E, Rafferty MR, David F, Sadowsky S, Corcos DM (date unknown). Effects of progressive resistance exercise training on the motor and non-motor features of Parkinson’s disease: a review. Vol. 4, 11-27. Accepted, .
  • Lamotte G, Coon EA, Suarez MD, Sandroni P, Benarroch E, Cutsforth-Gregory JK, Mauermann ML, Berini SE, Shouman K, Sletten D, Goodman BP, Low PA, Singer W (date unknown). Standardized Autonomic Testing in Patients With Probable Radiation-Induced Afferent Baroreflex Failure. Vol. 79, 50-56. Accepted, .
  • Castillo-Pinto C, Lamotte G, Mehta A, Sonti R, Di Maria G, Ruiz D, Kumar PN, Stemer AB, Denny MC (date unknown). Healthcare Worker With Large Vessel Acute Ischemic Stroke Likely Related to Mild SARS-CoV-2 Infection. Vol. 12, 48-56. Accepted, .
  • Lamotte G, Rafferty MR, Prodoehl J, Kohrt WM, Comella CL, Simuni T, Corcos DM (date unknown). Effects of endurance exercise training on the motor and non-motor features of Parkinson's disease: a review. Vol. 5, 21-41. Accepted, .
  • Zahid A, Coon EA, Lamotte G (date unknown). "No man is an island"-unique pattern of anhidrosis with islands of preserved sweat in Ross syndrome. (pp. 5399-5400). Vol. 42. Accepted, .
  • Cutsforth-Gregory JK, Benarroch EE, Lamotte G (date unknown). Platypnea-orthodeoxia syndrome mimicking postural orthostatic tachycardia syndrome. (pp. 573-576). Vol. 31. Accepted, .
  • Lamotte G, Cogez J, Viader F (date unknown). Interferon-β-1a-induced psychosis in a patient with multiple sclerosis. (pp. 462). Vol. 66. Accepted, .
  • Lamotte G, Sandroni P (date unknown). A case of Ross syndrome associated with systemic sclerosis. (pp. 463-465). Vol. 31. Accepted, .
  • Lamotte G, Laballe R, Dupuy B (date unknown). Bilateral eyelid retraction, loss of vision, ophthalmoplegia: an atypical triad in anti-GQ1b syndrome. (pp. 469-70). Vol. 170. Accepted, .
  • Chochol MD, Kataria L, OʼRourke MC, Lamotte G (date unknown). Clozapine-Associated Myoclonus and Stuttering Secondary to Smoking Cessation and Drug Interaction: A Case Report. (pp. 275-277). Vol. 39. Accepted, .
  • Lamotte G, Benarroch EE, Coon EA (date unknown). Paroxysmal hypothermia and hyperhidrosis with exacerbation after COVID-19 Infection. (pp. 327-329). Vol. 31. Accepted, .
  • Lamotte G, Caillot A, Di Palma C, Lechapt-Zalcman E, Benateau H, Cogez J (date unknown). Intramedullary metastasis of a cutaneous squamous cell carcinoma. (pp. 230-2). Vol. 170. Accepted, .
  • Lamotte G, Danaila TC, Jaillon-Rivière V, Hitier M, Defer GL (date unknown). Paraneoplastic opsoclonus myoclonus with autoantibodies to glutamic acid decarboxylase. (pp. 50-1). Vol. 170. Accepted, .
  • Lamotte G, Rafferty MR, Prodoehl J, Kohrt WM, Comella CL, Simuni T, Corcos DM (date unknown). Effects of Endurance Exercise Training on The Motor and Non-Motor Features of Parkinson's Disease: A Review. (pp. 993). Vol. 5. Accepted, .
  • Lamotte G, Rafferty MR, Prodoehl J, Kohrt WM, Comella CL, Simuni T, Corcos DM (date unknown). Effects of Endurance Exercise Training on The Motor and Non-Motor Features of Parkinson's Disease: A Review. (pp. 621). Vol. 5. Accepted, .